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Prion diseases reflect conformational conversion of benign isoforms of prion protein (PrP
C) to malignant PrP
Sc isoforms.
Networks perturbed by PrP
Sc accumulation and their ties to pathological events are poorly understood. Time-course
transcriptomic and phenotypic data in animal models are critical for understanding prion-perturbed networks in systems
biology studies. Here, we present the Prion Disease Database (PDDB), the most comprehensive data resource on mouse
prion diseases to date. The PDDB contains: (i) time-course mRNA measurements spanning the interval from prion inocula-
tion through appearance of clinical signs in eight mouse strain-prion strain combinations and (ii) histoblots showing
temporal PrP
Sc accumulation patterns in brains from each mouse–prion combination. To facilitate prion research,
the PDDB also provides a suite of analytical tools for reconstructing dynamic networks via integration of temporal
mRNA and interaction data and for analyzing these networks to generate hypotheses.
Database URL: http://prion.systemsbiology.net
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Introduction
With advances in high-throughput measurement technolo-
gies, huge amounts of global datasets have been generated
to study various human complex diseases. By analyzing
these global datasets, systems biology approaches are
being attempted to gain new insights into the pathophy-
siology of human diseases (1–3). Among the complex dis-
eases, prion diseases, which are fatal neurodegenerative
disorders found in humans and animals, are experimentally
tractable diseases with the availability of animal models
(inbred, transgenic and congenic mice), and thus they can
be studied effectively using systems biology approaches.
Prion diseases are caused by prions composed of misfolded
isoforms of the prion protein and characterized by the
following neuropathophysiological features: (i) PrP replica-
tion and accumulation, (ii) microglial and astrocyte activa-
tion, (iii) synaptic degeneration and (iv) neuronal cell
death (4,5). Prion pathology and the incubation times
(the interval between infection and disease) are varying
in different mouse strains (Table 1). In addition to genetic
influences on incubation time, there are distinct strains
of prions that determine disease duration, distribution
of lesions in the brain, and clinical signs. These strain
differences reflect structural differences in PrP
Sc isoforms.
To unravel the fundamental mechanisms underlying these
complex behaviors in prion diseases, there has been a
need for a wide spectrum of global datasets obtained
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strains.
Although several microarray studies have been per-
formed using different mouse models (6–8), the datasets
from these independent studies have been limited in
their information contents (i.e. lack of a broad range of
incubation times, a few mouse and prion strains, different
array platforms, etc.) and also have not been systematically
normalized and stored in a database for effective compara-
tive and integrative analyses across datasets from different
studies. Also, these studies have been limited to identifying
genes and cellular processes perturbed by prion disease
and have not exploited these findings to reconstruct dyna-
mical biological networks representing temporal activation
of these processes and their interactions. To resolve these
problems, we have recently applied a systems approach
to prion diseases (9), which involved: (i) generation of a
comprehensive time-course gene expression dataset as
well as temporal histoblots representing PrP
Sc accumulation
across brains in eight mouse–prion strain combinations;
(ii) an integrated collection of multiple layers of data
including protein interactions for network reconstruction,
GO annotations, KEGG/Biocarta pathways, and tissue speci-
ficity information; and (iii) integration of a suite of systems
biology tools for reconstructing dynamic networks that
describe fundamental processes perturbed during the
course of prion disease and their interactions.
Here, we present the Prion Disease Database (PDDB), the
most comprehensive data resource on mouse prion diseases
to date, which contains both the data generated in our
previous study (9) and provides an array of systems biology
tools we used during the analysis. The availability of pri-
mary experimental data from a comprehensive study is the
key attribute that distinguishes the PDDB from other neu-
rodegenerative disease databases such as AlzGene (10) for
Alzheimer’s Disease, HDBase (11) for Huntington’s Disease
and PDGene (12) for Parkinson’s Disease, which focus on
meta analysis of published manuscripts and data sets to
identify candidate disease genes.
The PDDB is a web-based resource for research in prion
disease and also for potential use in research on other com-
plex human diseases. It contains time-course data from over
450 microarrays and histoblots showing temporal PrP
Sc
accumulation patterns in brains from eight mouse–prion
strain combinations, as well as basic data exploration
tools and systems biology tools. The key tools integrated
into the PDDB are: (i) a search function coupled with two
visualization tools (heatmap and profile viewers) enabling
efficient exploration of temporal gene expression patterns
for sets of genes (e.g. a set of differentially expressed
genes); (ii) tools for network analyses linking the sets of
genes to protein interactions via Cytoscape and its plugins
and statistical and other systems biology tools supporting
the Gaggle interface (13); (iii) web-interfaces linking the
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NCBI gene page information and KEGG pathways as well
as tissue specificity information; and (iv) a function to
construct and store user-defined sets of genes, allowing
the users of the PDDB to employ the tools and data
of the PDDB for their own research questions.
Collectively, the temporal gene expression and histoblot
data and the suite of tools support diverse types of studies:
from simple studies inferring gene expression levels for
a particular set of genes to comprehensive systems biology
studies involving integration of data from the PDDB with
new data and network analysis of the integrated data.
Database
Database and website infrastructure
We based the PDDB on the GDxBase system developed
for the T1DBase (14), which comprises a relational database
management system (RDBMS) for data storage and integra-
tion with external data sources as well as a web-based
user interface for data exploration and visualization. The
GDxBase system also provides support to integrate external
data analysis tools. The database back-end consists of
several MySQL databases that are queried through the
Perl-driven web front-end that dynamically generates
HTML pages. Histoblots and protein-interaction networks
are located in the file system of the webserver, whereas
expression data is stored in one of the MySQL databases.
Both public and private, i.e. user-specific, gene sets are
stored in the database back-end as well and can be used
to query the PDDB for a predefined collection of genes.
Data are loaded into the database by administrators
through a collection of tools implemented in Perl.
Affymetrix probe identifiers of all probes on the microarray
type used in our project have been integrated with data
from external data sources such as Ensembl, dbSNP and
NCBI Entrez. The corresponding data is stored in the data-
base back-end and can be retrieved at the gene level.
Although most of the features of the PDDB are based
on the GDxBase framework, we have modified and
adapted some aspects of the functionality of the frame-
work to meet the requirements of the PDDB. To improve
the response time of the database when gene expression
profiles are searched for, we have optimized the database
schema for this type of query. As visualization of gene
expression profiles is one of our main concerns, we have
implemented our own version of the heatmap and profile
plot visualizations. We added the possibility to view expres-
sion data on either the gene- or the probe-level as an addi-
tional feature. The PDDB also provides interfaces to the
Gaggle environment (13) through the Firegoose Firefox
browser extension (15). Both lists of identifiers and expres-
sion data can be exchanged directly with tools and other
resources that support the Gaggle environment. Export
of data is facilitated through provision of the data in the
Gaggle microformat on search results pages. Import of
identifier lists is possible through a specialized website
handler that is used by the Firegoose to send data to the
PDDB.
Additional gene expression data sets can be loaded
into the PDDB if probe annotation for the corresponding
microarray platform is available. Beyond gene expression
data the database framework and interface of the
GDxBase can handle other data types as well. For instance,
integration of protein expression levels under different
conditions into the database is straightforward as long as
annotation for the measured proteins is provided. Relevant
quality and statistical measures on the expression profile
level can be deposited as well and retrieved through the
web interface.
Transcriptomic profiling and data analysis
We selected eight mouse–prion strain combinations with
two genetic backgrounds [C57BL/6J (B6) and FVB/NCr
(FVB)] and two alleles of Prnp [Prnp
a (B6 and FVB), Prnp
b
(B6.I)] in mouse as well as two prion strains (RML and 301V;
Table 1). The mice were inoculated intracerebrally with
brain homogenate from clinically ill mice with prion strain
for diseased samples. A description of the methods used
to generate the experimental data is available in our
recent paper (9). For time-course gene expression profiling,
we have used the Affymetrix Mouse Genome Chip 430 2.0
Array platform to measure mRNA abundance changes
in the brains of mice from the eight mouse–prion strain
combinations. Measurements were taken at 8–14 time
points where the harvest interval and the frequency of
measurements were dependent on incubation time as indi-
cated in Table 1. The log2-transformed time-series data
of each prion–host combination were normalized using
gcRMA normalization available in BioConductor (http://
www.bioconductor.org). A Monte Carlo simulation-based
parametric statistical testing method was then applied to
determine whether the gene is differentially expressed in
a consistent pattern over time (9). All log2-transformed
expression levels, P-values, additional measures resulting
from the aforementioned statistical test as well as quality
control flags (present/absent calls) are stored in the data-
base and can be retrieved through queries for the asso-
ciated genes. Overall the database contains roughly 20
million data points for a total of about 45000 probes,
measured in triplicate under approximately 180 different
conditions.
Generation of histoblots showing PrP
Sc accumulation
The brain histoblot images contained in the PDDB
were brain slices transferred to nitrocellulose, PK-digested
and stained with human Fab D18 anti-PrP to display
.............................................................................................................................................................................................................................................................................................
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Sc during the progress
of the prion disease (9). PK resistance is a widely used sur-
rogate marker for detecting PrP
Sc. Both time-series and
end-point histoblots of coronal and sagittal brain sections
are presented for the prion–host combinations. All time-
series histoblots are coronal sections with the exception
of FVB-Tg(PrP-A)B4053. The earliest time point presented
in each case is the last one that was indistinguishable
from a control, uninfected brain section processed at the
same time. While all prion inoculations were done in the
right hemisphere targeting the thalamus, we have brain
sections created from both the left and the right hemi-
sphere during the course of disease progression. End-
point histoblots are available for sagittal sections taken
from the mid-line brain moving out laterally from several
regions for each prion–host combination in high resolution.
The histoblots are available as either JPEG or PNG images.
Construction and maintenance of gene sets
Regular users of the PDDB have the option to create a user
account to get access to the ‘My PDDB’ feature. This feature
enables the creation of sets of genes that can be used
for instance to search the expression data or to generate
a hypothetical protein interaction network for exploration
in Cytoscape. Through the My PDDB interface the user may
examine and edit user-defined and the public pre-defined
lists. This feature is useful to store the results of analyses
such as we have done for example with the top differen-
tially expressed genes in our study. Alternatively, genes
involved in a certain pathway or biological process can be
stored as a set as well as collections of genes that are
the result of an analysis performed by the user. While our
sets of top differentially expressed genes are publicly avail-
able the sets created by users are private but can be made
public if desired. In future sessions the user will then be
able to quickly retrieve previously created sets of genes
and corresponding expression profiles or interaction net-
works. This contributes greatly to more efficient data
exploration and analysis with the PDDB.
Software
Overview of the web interface of the PDDB
The goal of the PDDB is to provide not only fundamental
dynamic molecular and histological data, but also data
exploration tools for generation of network-driven hypoth-
eses in systems biology research on prion diseases. The web
interface of the PDDB provides several entry points to
the data contained in the database (see the menu bar indi-
cated by the arrow in Figure 1). In the ‘Search’ submenu,
the menu item ‘Microarray Data’ provides access to
advanced search interfaces for gene expression patterns
across the whole collection of time-course microarray data
(Table 1). To facilitate the search, the PDDB also provides
‘Connect the Dots’, a GDxBase tool (14) that can convert
one type of gene or protein identifier into another to be
used for the search (see an example in Supplementary
Figure 1).
The ‘Download’ submenu provides access to raw gene
expression data files (Affymetrix CEL files; Supplementary
Figure 2). The ‘Analysis & Tools’ section gives an overview
of several computational and network analysis tools that
can be employed to investigate functional roles of a set
of genes using biological networks. The tools are categor-
ized as follows (Supplementary Figure 3): (i) Network
Analysis-Cytoscape (16) and BioTapestry (17) to analyze
protein and gene regulatory networks, respectively;
(ii) Pathway Analysis- DAVID (18) for pathway enrichment
analysis and KEGG for pathway exploration; (iii)
Visualization and Statistical Analysis- Mayday (19) and
Prequips (20) to visualize and analyze gene expression
and proteomics data, respectively; and (iv) Transcription
Factor Analysis- MotifMogul [http://xerad.systems-biology
.net/MotifMogulServer (21)] for in silico gene regulatory
network analysis. Also, a brief overview of the history,
background and pathology of prion disease as well as
mouse brain histoblots are provided in the ‘Prion Disease’
section (Supplementary Figure 4). The ‘Research’ section
contains additional details on our systems biology approach
to prion diseases (Supplementary Figure 5). The ‘My PDDB’
section allows users to create an account where they can
store their own sets of genes and use them to explore
the data in the PDDB more efficiently (Supplementary
Figure 6).
Search and visualization of temporal gene expression
patterns for data exploration
As the most comprehensive data resource on prion diseases,
the PDDB contains mRNA expression datasets generated
from the following eight mouse–prion strain combinations
involving two prion strains and six lines of mice that exhib-
ited different prion disease phenotypes: (i) five mouse
strains infected with two prion strains of RML and 301V-
BL6-RML, BL6.I-RML, BL6-301V, BL6.I-301V and FVB-RML;
and (ii) three FVB transgenic mouse strains infected
with RML-Tg4053-RML, FVB(0/+)-RML and FVB(0/0)-RML
(see Table 1 for further details). To effectively explore tem-
poral gene expression patterns for a particular set of genes
in such datasets, the PDDB provides a search function
coupled with two visualization tools—heatmaps and pro-
file plots. Performing a search involves the following steps
(Figure 1): (i) first enter a list of genes into the ‘Enter Any
Gene Identifiers’ section using gene symbols or Entrez IDs
or selection of a predefined set of genes: for example, the
top 20 differentially expressed genes (DEGs) shared in the
five aforementioned mouse–prion strain combinations (see
the red box in the ‘Step 1’ panel of Figure 1A) and (ii) select
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................Figure 1. Exploration of temporal gene expression profiles. (A) Gene expression search comprising (i) selection of a predefined
set of genes (top 20 shared DEGs) or entering of a set of the genes to be explored and (ii) selection of a set of mouse–prion
strain combinations to be searched. (B) Heatmaps and profile plots showing temporal gene expression patterns of the top 20
shared DEGs in all mouse–prion strain combinations. (C) Log2 fold changes of the top 20 shared DEGs in the combinations (only
the fold changes in BL6-RML are shown).
.............................................................................................................................................................................................................................................................................................
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expression data are to be retrieved (see the ‘Step 2’ panel
in Figure 1A and Supplementary Figure 7A). Figure 1B
shows the retrieved expression patterns for the top 20
shared DEGs both as heatmap and profile plot (see also
Supplementary Figure 7B). The expression pattern shows
that the expression changes were similar across all strain
combinations and highly correlated within each combina-
tion. However, the time point at which the expression levels
of the shared genes began to increase is different in each
combination—the genes in the mouse–prion combinations
(BL6-RML, BL6.I-301V and FVB-RML) with short incubation
times were changed earlier than those in the combinations
with long incubation times (BL6-301V and BL6.I-RML). One
can reconstruct a dynamic network for the shared DEGs
to predict biological relevance of such differences in prion
pathogenesis.
For genes represented by multiple probesets on the
microarray the PDDB provides three different options to
display its temporal expression levels in the heatmap and
profile plot (see the blue box in Supplementary Figure 7B):
(i) an averaged expression profile of all probesets of the
gene (‘Average Probeset’ mode), (ii) an expression profile
of the probeset with the lowest P-value (‘Top P-value
Probeset’ mode), or (iii) the expression profiles of all pro-
besets (‘All Probesets’ mode). The user can also review the
search results in tabular form. Figure 1C shows two tables,
one with the temporal fold changes (Supplementary
Figure 7C) and the other with the statistical measures
(Supplementary Figure 7D) computed by the method used
determine the DEGs (9). The fold changes and P-values can
be downloaded by clicking the links to tab-delimited text
files for further analysis in external tools (see the red box
in Supplementary Figure 7C).
Network reconstruction and exploration tools
The PDDB provides access to tools for reconstruction and
exploration of hypothetical networks describing essential
cellular processes implicated in prion diseases, leading
to generation of network-driven hypotheses about funda-
mental principles of prion pathogenesis. The PDDB provides
access to two tools for network analysis; Cytoscape
and BioTapestry (see ‘Network Analysis’ in the green
box of Figure 2A). Note that network modeling using
BioTapestry is possible through the Gaggle while network
analysis using Cytoscape is possible within the PDDB
and also via the Gaggle (see below). For network analysis
using Cytoscape within the PDDB, we first select a set
of genes (e.g. top 20 shared DEGs), choose ‘Start with:
Your own list of Human Entrez Gene IDs’ option (see the
blue box in Figure 2A), and enter Entrez IDs of these
selected genes. Then, a subnetwork for these genes can
be reconstructed using protein interactions queried from
several databases such as BIND and HPRD by clicking the
‘Start’ button. Users can specify which interaction data-
bases are to be used and choose a network depth, e.g. ‘1’
for the first neighbors of the genes (Supplementary
Figure 8).
Instead of reconstructing a hypothetical network for a
user-defined set of genes, the PDDB also provides three
predefined networks closely related to prion pathogenesis:
(i) Glial Activation (see the red box in Figure 2A), (ii) PrP
Sc
Accumulation and (iii) Neurodegeneration networks.
Figure 2B shows the ‘Glial Activation’ network describing
immune responses to PrP
Sc accumulation, including comple-
ment activation, cytokines/chemokines, and cell adhesion
molecules. These predefined networks can serve as plat-
form networks that can be expanded further into more
comprehensive networks using Cytoscape plugins [cPath
and MiMI (22,23)]. Using these Cytoscape plugins, the
PDDB allows us to perform various types of network
exploration (Supplementary Figure 9): for a hypothetical
network reconstructed using a set of genes, (i) GO enrich-
ment analysis for all network nodes using BiNGO (24),
(ii) clustering of network nodes using MCODE (15) to iden-
tify network modules, (iii) identification of active network
modules using jActiveModules (25) and (iv) expansion of
an existing network using MiMI.
Statistical and systems biology analysis using external
tools integrated into the PDDB via the Gaggle
The integration of the PDDB into the Gaggle environment
allows the users to directly exchange data between a wide
range of systems biology applications. The Gaggle makes
exploration of complex, heterogeneous data sets more
efficient and enables the user to analyze the data within
the PDDB with external analysis tools without any admin-
istrative overhead such as reformatting of data files.
Figure 3 illustrates an exemplary workflow of how we
can use the external tools in the PDDB through the
Gaggle. An interaction network is created within the
PDDB and loaded into Cytoscape through Java Webstart
(Figure 3A). The gene symbols of all nodes in the network
are then sent back to the PDDB through the CyGoose
plugin (Figure 3B). The PDDB receives the list of gene sym-
bols from the Firegoose and automatically populates the
query form in the Microarray Expression page (Figure 3C).
The query results page provides heatmaps and profile plots
of the retrieved expression matrices (Figure 3D). The results
are then broadcast to Cytoscape where the expression
levels are used to color the network nodes (Figure 3E).
This allows the user to identify co-expressed, interacting
proteins, e.g. by looking for clusters of nodes that have
the same color or through analysis of the network with a
Cytoscape plugin. At the same time the expression data
can be sent to TIGR MeV (26), where clustering is per-
formed to find genes that are co-expressed over all condi-
tions in the expression matrix (Figure 3F). At this point the
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................Figure 2. Reconstruction and exploration of hypothetical networks. (A) Network reconstruction involving either selection of
a predefined network from our study or entering a set of genes for which a network can be built. (B) A glial activation network
describing diverse immune responses to prion accumulation (see the text for further details). This example network can serve
as a platform network to build more comprehensive networks by expanding particular network modules to include relevant
cellular processes.
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.............................................................................................................................................................................................................................................................................................user could send identifiers from a particular cluster back
to the PDDB to query their expression levels under further
conditions and then broadcast those to Cytoscape to visua-
lize this data on the interaction network.
Integration of heterogeneous types of data to support
network exploration
Mapping dynamic changes of expression levels of genes
belonging to key network modules into those of PrP
Sc
accumulation is critical in evaluating their relevance to
and also predicting their functional roles in prion patho-
genesis. To assist in the mapping of dynamic changes in
transcriptional patterns and PrP
Sc accumulation, the PDDB
provides time-course histoblots representing PrP
Sc accumu-
lation in all mouse–prion strain combinations (Table 2).
Figure 4 shows an example set of histoblots obtained
from left and right hemispheres of Tg4053 mice infected
with RML at every week from 4 to 9 weeks during disease
Figure 3. Exchange of data between the PDDB and external tools through the Gaggle. (A) Network reconstruction within the
PDDB. (B) Loading the network into Cytoscape through Java Webstart. (C) Broadcasting the gene symbols corresponding to
the network nodes back to the PDDB through the CyGoose. (D) Querying the PDDB for the list of gene symbols from CyGoose in
the Microarray Expression page. (E) The retrieved expression matrices can be broadcast back to Cytoscape through the Firegoose
and be used to provide node colors using VizMapper. (F) The expression matrices can be also broadcast to other tools such as
the TIGR MeV for further analyses (e.g. clustering). See the text for further details.
.............................................................................................................................................................................................................................................................................................
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Sc accumulation became first apparent
after 49 days post-inoculation when the expression levels
of the top 20 shared DEGs began to increase in Tg4053-RML
(see the consistent dynamics between the gene expression
changes shown in the dotted box in Figure 1B and the
histoblots in Figure 4). This suggests that these genes
might play key roles in cellular events (e.g. prion replica-
tion) occurring during the early phase of prion infection.
The PDDB also provides other types of relevant informa-
tion such as (i) abundances of mRNAs across 30 types
of tissues (27) and (ii) so-called ‘Gene Page’ annotation
information including Gene Ontology information, protein
interactions, KEGG/Biocarta pathways, and genetic associa-
tion information. The tissue specificity information can
be used to support prediction of diagnostic marker candi-
dates indicating physiological changes in a specific target
organ (i.e. brain in prion disease) out of a set of DEGs
(e.g. top 20 shared DEGs) identified from the time-course
gene expression data.
Figure 5A shows the ‘Gene Page’ information for an
example gene GFAP. According to KEGG and Biocarta,
GFAP is a structural component of intermediate filaments
(see the red box in Figure 5A) and is involved in prion dis-
ease pathway as an indicator of gliosis, a key early event
during prion infection. Also, the brain specific expression
pattern of GFAP, as indicated by relatively high abundance
in the nervous system as shown in Figure 5B, suggests
that it reflects physiological changes occurring during
the progress of prion disease. A subset of these nervous
systems proteins that can be secreted into the extracellular
space and further into the blood stream can serve as excel-
lent candidates for serum diagnostic markers. A network
including GFAP can be reconstructed using protein interac-
tions from the ‘Gene Page’ (see the blue box in Figure 5),
Table 2. Time-course histoblots representing accumulation of proteinase K-resistant PrP
Sc in brains infected by prions
Mouse-prion strain combinations
(mouse strain–prion strain)
Histoblots, Sagittal
(day post-inoculation)
Histoblots, Coronal (day post-inoculation)
C57BL/6J (B6)—RML 154 Control, 42, 67, 82, 98, 110, 128, 138 and 154
C57BL/6J (B6)—301V 252 Control, 111, 138, 167, 196 and 224
C57BL/6.I-1 (B6.I)—RML 365 Control, 170, 195, 224, 252, 335 and 365
C57BL/6.I-1 (B6.I)—301V 126 Control, 55, 70, 83, 98, 111 and 126
FVB/NCr (FVB)—RML 154 Control, 41, 56, 69, 84, 98, 112, 126 and 142
Tg(MoPrP-A)B4053 (Tg4053)—RML Control, 28, 35, 42, 49,
57, 60, 63
(FVB x FVB.129-Prnp
tm1Zrch)F1 (Prnp0/+)—RML Control, 168, 279, 389 Control, 54, 85, 111, 168, 195, 223, 252, 279, 319,
336, 362 and 389
Histoblots from both sagittal and coronal sections of prion-infected brains were generated from the eight mouse–prion strain combina-
tions. While all prion inoculations were done in the right hemisphere targeting the thalamus, we have brain sections created from both
the left and the right hemisphere during the course of disease progression. The earliest time point presented in each case is the last one
that was indistinguishable from a control, uninfected brain section processed at the same time. With an exception of Tg4053-RML
combination, the PDDB provides time-course coronal histoblots with the similar time intervals used in mRNA studies. However, the
PDDB provides only two time-course sagittal histoblots from Tg4053-RML and Prnp0/+-RML combinations while it provides sagittal
histoblots at a single time point near the terminal stage for the rest of mouse–prion strain combinations.
Figure 4. Histoblots representing PrP
Sc accumulation during the course of prion infection. An example set of histoblots from left
and right brain hemispheres of Tg4053-RML showing significant PrP
Sc accumulation after 49 days.
.............................................................................................................................................................................................................................................................................................
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.............................................................................................................................................................................................................................................................................................Figure 5. Gene page information. (A) Protein interactions (the blue box), and database information (KEGG and Biocarta
pathways and GO information). (B) Tissue specific expression information that can support prediction of diagnostic marker
candidates.
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all these resources, including temporal gene expression
changes, histoblots and all the ‘Gene Page’ information,
coupled with the suite of the analysis tools in the PDDB
collectively support various systems biology studies on
prion diseases.
Conclusions and outlook
In this article we presented the PDDB, an on-line resource
that provides dynamic expression data and histoblots
documenting the progression of prion infection in eight
different mouse–prion strain combinations, as well as
access to a suite of tools for data visualization, exploration,
and network reconstruction and analysis. Since the
GDxBase software and all other tools used in the construc-
tion of the PDDB are freely available, the PDDB can serve
as an example for authors of other systems biology
studies, who are considering making their data and
methods readily available to the community. As we have
shown, generic frameworks such as the GDxBase can be
extended into custom solutions that provide more func-
tionality than for instance public data repositories, which
typically hold only one type of data.
The integration of data and tools in the PDDB helps
scientists explore relationships in the data efficiently and
collectively evaluate the data. This will make it easier to
formulate or cross-check quickly both knowledge-driven
hypotheses and hypotheses generated from the data in
individual laboratories about key factors involved in funda-
mental cellular events occurring during the progress of
prion disease using both the data and the tools of the
PDDB. For instance, it could be used to determine whether
a gene plays a role in or its expression level is affected by
the progression of prion disease. A gene whose expression
levels exhibit (i) consistent increase or decrease during
the progress of the disease in any of the five standard
mouse–prion strain combinations from Table 1, (ii) increase
in the transgenic mice overexpressing Prnp [FVB-Tg
(PrP-A)B4053], and 3) no significant increase in the other
transgenic mice lacking both alleles of the Prnp gene
(FVB.Prnp0/0) is likely to be involved in or affected by
prion replication during the early phase of prion infection.
Also, the expression data search function can be used
to quickly check if a particular set of genes that a user
found from his/her own studies using different prion–host
combinations is also differentially expressed also in the
eight prion-mouse combinations in the PDDB for their
general validity. Thus, we believe that the PDDB serves
as a public data repository from which a wide spectrum
of researchers studying prion and other neurodegenerative
disease will benefit as it represents a comprehensive
context that can be utilized for interpretation of their
own data.
We plan to extend the PDDB in the future to include
(i) more types of data (e.g. proteomic data from serum
samples from prion infected mice, microRNA data, addi-
tional mRNA profiles from peripheral blood mononuclear
cells (PBMCs) and spleen and other types of inbred mice,
congenic and transgenic mice, etc.) that we have accumu-
lated; and (ii) publicly available data (e.g. mRNA profiles
previously published and proteomic data) that we have
been collecting.
Supplementary data
Supplementary data are available at Database Online.
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